- Home
- MURA vs UONEK Comparison
MURA vs UONEK Comparison
Compare MURA & UONEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MURA
- UONEK
- Stock Information
- Founded
- MURA 2013
- UONEK 1980
- Country
- MURA Ireland
- UONEK United States
- Employees
- MURA N/A
- UONEK N/A
- Industry
- MURA
- UONEK Broadcasting
- Sector
- MURA
- UONEK Consumer Discretionary
- Exchange
- MURA Nasdaq
- UONEK Nasdaq
- Market Cap
- MURA 30.7M
- UONEK 28.1M
- IPO Year
- MURA N/A
- UONEK N/A
- Fundamental
- Price
- MURA $1.82
- UONEK $0.74
- Analyst Decision
- MURA Strong Buy
- UONEK
- Analyst Count
- MURA 3
- UONEK 0
- Target Price
- MURA $12.00
- UONEK N/A
- AVG Volume (30 Days)
- MURA 281.7K
- UONEK 24.0K
- Earning Date
- MURA 08-04-2025
- UONEK 08-13-2025
- Dividend Yield
- MURA N/A
- UONEK N/A
- EPS Growth
- MURA N/A
- UONEK N/A
- EPS
- MURA N/A
- UONEK N/A
- Revenue
- MURA N/A
- UONEK $411,386,000.00
- Revenue This Year
- MURA N/A
- UONEK N/A
- Revenue Next Year
- MURA N/A
- UONEK N/A
- P/E Ratio
- MURA N/A
- UONEK N/A
- Revenue Growth
- MURA N/A
- UONEK N/A
- 52 Week Low
- MURA $0.95
- UONEK $0.44
- 52 Week High
- MURA $4.74
- UONEK $1.44
- Technical
- Relative Strength Index (RSI)
- MURA 36.95
- UONEK 60.22
- Support Level
- MURA $1.53
- UONEK $0.63
- Resistance Level
- MURA $1.83
- UONEK $0.69
- Average True Range (ATR)
- MURA 0.17
- UONEK 0.04
- MACD
- MURA -0.01
- UONEK 0.01
- Stochastic Oscillator
- MURA 33.33
- UONEK 79.79
About MURA Mural Oncology plc
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.
About UONEK Urban One Inc. Class D
Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.